QUOTE AND NEWS
Benzinga  Oct 6  Comment 
RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for its application claiming methods for treating, preventing, inhibiting or reducing tissue...
FierceBiotech  Apr 14  Comment 
RegeneRx, a Rockville, MD-based biopharmaceutical company, has decided to put most of its resources for the near term into its dry eye treatment, RGN-259, the company announced in a news release. This shift in focus comes after some recent...
StreetInsider.com  Apr 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RegeneRx+%28RGRX%29+Refocuses+on+RGN-259+Development/6428281.html for the full story.
StreetInsider.com  Apr 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RegeneRx+%28RGRX%29+Reports+RGN-259+Achieves+Statistical+Significance+in+Recent+Model/6426050.html for the full story.
FierceBiotech  Mar 16  Comment 
RegeneRx has been forced to slam the brakes on a mid-stage study of RGN-352, its injectable formulation of Thymosin beta 4 for acute myocardial infarction. According to the company, regulators said that its contract manufacturer wasn't compliant...
StreetInsider.com  Nov 17  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RegeneRx+%28RGN%29+Receives+Patent+Approval+for+T%C3%8E%C2%B24+Use+in+Australia/6113900.html for the full story.
StreetInsider.com  Jul 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RegeneRx+Biopharma+%28RGN%29+Receives+Australian+Patent+for+T%CE%B24/5790868.html for the full story.
StreetInsider.com  May 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RegeneRx+Biopharma+%28RGN%29+Announces+POsitive+Results+in+Thymosin+Beta+4+Study/5666320.html for the full story.
StreetInsider.com  May 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/RegeneRx+Biopharma+%28RGN%29+Prices+11.5M+Common+Unit+Offering+at+%240.41Unit/5649393.html for the full story.
StreetInsider.com  Apr 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/RegeneRx+Biopharma+%28RGN%29+Announces+Common+Offering/5539212.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki